Medicine & Life Sciences
Positron-Emission Tomography
100%
Positron Emission Tomography Computed Tomography
97%
Fluorodeoxyglucose F18
71%
Neoplasms
61%
Prostatic Neoplasms
48%
Neoplasm Metastasis
46%
Bone and Bones
37%
fluciclovine F-18
37%
Therapeutics
31%
Breast Neoplasms
30%
Drug Therapy
23%
Single-Photon Emission-Computed Tomography
22%
Prostate-Specific Antigen
22%
Non-Small Cell Lung Carcinoma
22%
Survival
22%
Radiopharmaceuticals
21%
Radiotherapy
20%
Radioisotopes
20%
Tomography
20%
Esophageal Neoplasms
20%
Radionuclide Imaging
19%
Nuclear Medicine
18%
Lymphoma
18%
Rituximab
17%
Biopsy
17%
Paraganglioma
16%
Progression-Free Survival
15%
Lymph Nodes
15%
Radium-223
15%
Tumor Burden
15%
Single Photon Emission Computed Tomography Computed Tomography
14%
dotatate gallium ga-68
14%
Radioimmunotherapy
14%
Melanoma
14%
Recurrence
14%
Lymphoma, Large B-Cell, Diffuse
14%
Carcinoma
13%
Hodgkin Disease
13%
Guidelines
13%
Doxorubicin
12%
Adenocarcinoma
12%
Lung Neoplasms
12%
Radiation
12%
Prostate
12%
Radiometry
12%
Neuroendocrine Tumors
12%
Gastrointestinal Stromal Tumors
12%
Deoxyglucose
11%
Lymphoscintigraphy
11%
Molecular Imaging
11%
Practice Guidelines
11%
Monoclonal Antibodies
11%
Colorectal Neoplasms
11%
Pheochromocytoma
10%
Glycolysis
10%
Sarcoma
10%
Electrons
10%
Sodium Fluoride
10%
Liver
9%
Inflammatory Breast Neoplasms
9%
B-Cell Lymphoma
9%
Non-Hodgkin's Lymphoma
9%
Thorax
9%
Breast
9%
Neck
9%
Technetium Tc 99m Medronate
9%
Lymph Node Excision
9%
Mantle-Cell Lymphoma
9%
Cyclophosphamide
9%
Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))
8%
Sensitivity and Specificity
8%
Protons
8%
Pentetic Acid
8%
Gallium
8%
Imatinib Mesylate
8%
Fluorides
8%
Prostatectomy
8%
Vincristine
8%
Magnetic Resonance Imaging
8%
Fluorine-18
7%
Parathyroid Neoplasms
7%
Lung
7%
Clinical Trials
7%
Indium-111
7%
Safety
7%
Glucose
7%
Bone Marrow
7%
Response Evaluation Criteria in Solid Tumors
7%
Residual Neoplasm
7%
Head
7%
Membranes
6%
Sarcoidosis
6%
Sentinel Lymph Node
6%
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6%
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)
6%
Androgens
6%
3-Iodobenzylguanidine
6%
Osteosarcoma
6%
Artifacts
6%